Clinical target volume segmentation based on gross tumor volume using deep learning for head and neck cancer treatment.

Researchers

Journal

Modalities

Models

Abstract

Accurate clinical target volume (CTV) delineation is important for head and neck intensity-modulated radiation therapy. However, delineation is time-consuming and susceptible to interobserver variability (IOV). Based on a manual contouring process commonly used in clinical practice, we developed a deep learning (DL)-based method to delineate a low-risk CTV with computed tomography (CT) and gross tumor volume (GTV) input and compared it with a CT-only input. A total of 310 patients with oropharynx cancer were randomly divided into the training set (250) and test set (60). The low-risk CTV and primary GTV contours were used to generate label data for the input and ground truth. A 3D U-Net with a two-channel input of CT and GTV (U-NetGTV) was proposed and its performance was compared with a U-Net with only CT input (U-NetCT). The Dice similarity coefficient (DSC) and average Hausdorff distance (AHD) were evaluated. The time required to predict the CTV was 0.86 s per patient. U-NetGTV showed a significantly higher mean DSC value than U-NetCT (0.80 ± 0.03 and 0.76 ± 0.05) and a significantly lower mean AHD value (3.0 ± 0.5 mm vs 3.5 ± 0.7 mm). Compared to the existing DL method with only CT input, the proposed GTV-based segmentation using DL showed a more precise low-risk CTV segmentation for head and neck cancer. Our findings suggest that the proposed method could reduce the contouring time of a low-risk CTV, allowing the standardization of target delineations for head and neck cancer.Copyright © 2022 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.